Somatogen (SMTG) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Somatogen (SMTG)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Kirce Stojanovski who wrote (320)	11/17/1997 4:20:00 PM
From: Jeff Clegg	Read Replies (1) of 442

Called IR today and got an update. CPB Phase II trials: Part A (1 to 2 units of Optro) Part AI (Patients undergoing 1st open heart surgery) This has been completed. Part AII (Patients undergoing 2nd open heart surgery) This part involves less patients than AI but takes longer because there are less people to chose from. This part is ongoing and may be complete by the end of the year. Then the data will have to be "un-blinded" and analyzed before the data is released to the public. Looking for February timeframe before the stock starts to move again. Any thoughts? P.S. # of participating hospitals may have increased from 4 to 6. Regards, Jeff

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next